Josef Brock

604 total citations
27 papers, 471 citations indexed

About

Josef Brock is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Josef Brock has authored 27 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Josef Brock's work include Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Josef Brock is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Josef Brock collaborates with scholars based in Germany, United States and Japan. Josef Brock's co-authors include Thomas Bittorf, Robert Jaster, Hans‐Dieter Volk, Manfred Lehmann, Tom Büchse, Frank Emmrich, Cornelia Platzer, Hermann Walzel, Angela Siegling and Jens Seiler and has published in prestigious journals such as Journal of Biological Chemistry, European Journal of Biochemistry and European Journal of Immunology.

In The Last Decade

Josef Brock

26 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josef Brock Germany 14 211 179 134 91 61 27 471
Titus Sparna Germany 7 80 0.4× 204 1.1× 44 0.3× 48 0.5× 43 0.7× 8 417
Raquel Grau Spain 8 105 0.5× 314 1.8× 75 0.6× 26 0.3× 37 0.6× 8 543
Zuyue Sun China 7 119 0.6× 348 1.9× 81 0.6× 17 0.2× 66 1.1× 14 572
Antti Ropponen Finland 12 118 0.6× 192 1.1× 89 0.7× 77 0.8× 12 0.2× 24 382
Elisa Ferrari Italy 7 82 0.4× 268 1.5× 89 0.7× 28 0.3× 28 0.5× 9 431
Tom Büchse Germany 8 161 0.8× 245 1.4× 90 0.7× 97 1.1× 26 0.4× 10 446
Xinyun Xu China 11 199 0.9× 266 1.5× 183 1.4× 57 0.6× 40 0.7× 24 572
Marta Derecka United States 10 171 0.8× 289 1.6× 176 1.3× 67 0.7× 26 0.4× 16 553
Katja Björklöf Switzerland 7 105 0.5× 384 2.1× 90 0.7× 53 0.6× 42 0.7× 12 536
I. L. O. Ponting United Kingdom 9 177 0.8× 213 1.2× 81 0.6× 171 1.9× 18 0.3× 12 511

Countries citing papers authored by Josef Brock

Since Specialization
Citations

This map shows the geographic impact of Josef Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Brock more than expected).

Fields of papers citing papers by Josef Brock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Brock. The network helps show where Josef Brock may publish in the future.

Co-authorship network of co-authors of Josef Brock

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Brock. A scholar is included among the top collaborators of Josef Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Brock. Josef Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Büchse, Tom, et al.. (2005). Phosphoprotein profiling of erythropoietin receptor‐ dependent pathways using different proteomic strategies. PROTEOMICS. 5(1). 91–100. 14 indexed citations
2.
Büchse, Tom, et al.. (2005). Profiling of Early Gene Expression Induced by Erythropoietin Receptor Structural Variants. Journal of Biological Chemistry. 281(12). 7697–7707. 6 indexed citations
3.
Kotsch, Katja, Josef Brock, Peter Nickel, et al.. (2004). FTY720 Prevents Anti-CD4 mAb-Induced Tolerance but Cannot Reverse Established Tolerance in a Rat Kidney Transplantation Model. American Journal of Transplantation. 4(6). 863–871. 6 indexed citations
4.
Sawitzki, Birgit, Manfred Lehmann, Katrin Vogt, et al.. (2002). Bag-1 up-regulation in anti-CD4 mAb-treated allo-activated T cell confers resistance to activation-induced cell death (AICD). Transplant Immunology. 9(2-4). 83–91. 4 indexed citations
5.
Sawitzki, Birgit, Manfred Lehmann, Katrin Vogt, et al.. (2002). Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. European Journal of Immunology. 32(3). 800–800. 16 indexed citations
7.
Walzel, Hermann, et al.. (2002). Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. Cellular Signalling. 14(10). 861–868. 28 indexed citations
8.
Bittorf, Thomas, et al.. (2001). Activation of the transcription factor NF-κB by the erythropoietin receptor. Cellular Signalling. 13(9). 673–681. 62 indexed citations
9.
Bittorf, Thomas, Hermann Walzel, Josef Brock, et al.. (2000). High Concentration of Soluble HLA-DR in the Synovial Fluid: Generation and Significance in “Rheumatoid-like” Inflammatory Joint Diseases. Cellular Immunology. 206(2). 85–100. 15 indexed citations
10.
Bittorf, Thomas, Jens Seiler, Zhihong Zhang, Robert Jaster, & Josef Brock. (1999). SHP1 Protein Tyrosine Phosphatase Negatively Modulates Erythroid Differentiation and Suppression of Apoptosis in J2E Erythroleukemic Cells. Biological Chemistry. 380(10). 1201–9. 34 indexed citations
11.
Jaster, Robert, et al.. (1999). Role of STAT5 in Interferon-α Signal Transduction in Ba/F3 Cells. Cellular Signalling. 11(5). 331–335. 12 indexed citations
12.
Jaster, Robert, et al.. (1999). Interferon-alpha Inhibits Proliferation of Ba/F3 Cells by Interfering with Interleukin-3 Action. Cellular Signalling. 11(10). 769–775. 14 indexed citations
13.
Jaster, Robert, Thomas Bittorf, & Josef Brock. (1997). Involvement of Phosphatidylinositol 3-Kinase in the Mediation of Erythropoietin-Induced Activation of p70S6k. Cellular Signalling. 9(2). 175–179. 18 indexed citations
14.
Bittorf, Thomas, et al.. (1997). Requirement for JAK2 inErythropoietin-Induced Signalling Pathways. Cellular Signalling. 9(1). 85–89. 40 indexed citations
15.
Walzel, Hermann, et al.. (1996). Cell calcium signalling induced by endogenous lectin carbohydrate interaction in the Jurkat T cell line. Glycoconjugate Journal. 13(1). 99–105. 13 indexed citations
17.
Bittorf, Thomas, Robert Jaster, & Josef Brock. (1994). Rapid activation of the MAP kinase pathway in hematopoietic cells by erythropoietin, granulocyte-macrophage colony-stimulating factor and interleukin-3. Cellular Signalling. 6(3). 305–311. 41 indexed citations
18.
Siegling, Angela, Manfred Lehmann, Cornelia Platzer, et al.. (1994). A NONDEPLETING ANTI-RAT CD4 MONOCLONAL ANTIBODY THAT SUPPRESSES T HELPER 1-LIKE BUT NOT T HELPER 2-LIKE INTRAGRAFT LYMPHOKINE SECRETION INDUCES LONG-TERM SURVIVAL OF RENAL ALLOGRAFTS. Transplantation. 57(3). 464–467. 65 indexed citations
19.
Lehmann, Manfred, et al.. (1992). INDUCTION OF LONG-TERM SURVIVAL OF RAT SKIN ALLOGRAFTS BY A NOVEL, HIGHLY EFFICIENT ANTI-CD4 MONOCLONAL ANTIBODY. Transplantation. 54(6). 959–962. 32 indexed citations
20.
Brock, Josef, et al.. (1973). Grundlagen der Immunologie. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026